PNC Financial Services Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-397
| Closed | -$2K | – | 4183 |
|
|
2019
Q4 | $2K | Sell |
397
-2,900
| -88% | -$13.6K | ﹤0.01% | 3848 |
|
|
2019
Q3 | $16K | Buy |
3,297
+1,344
| +69% | +$7.52K | ﹤0.01% | 3429 |
|
|
2019
Q2 | $11K | Buy |
1,953
+1,235
| +172% | +$6.56K | ﹤0.01% | 3547 |
|
|
2019
Q1 | $4K | Sell |
718
-1,190
| -62% | -$12.3K | ﹤0.01% | 3809 |
|
|
2018
Q4 | $26K | Buy |
1,908
+186
| +11% | +$3.14K | ﹤0.01% | 3200 |
|
|
2018
Q3 | $33K | Sell |
1,722
-13,434
| -89% | -$286K | ﹤0.01% | 3239 |
|
|
2018
Q2 | $388K | Sell |
15,156
-2,109
| -12% | -$49.2K | ﹤0.01% | 1798 |
|
|
2018
Q1 | $347K | Sell |
17,265
-3,345
| -16% | -$78K | ﹤0.01% | 1841 |
|
|
2017
Q4 | $414K | Buy |
20,610
+11,012
| +115% | +$217K | ﹤0.01% | 1755 |
|
|
2017
Q3 | $200K | Buy |
9,598
+819
| +9% | +$13.8K | ﹤0.01% | 2144 |
|
|
2017
Q2 | $130K | Buy |
8,779
+2,794
| +47% | +$46.6K | ﹤0.01% | 2377 |
|
|
2017
Q1 | $95K | Buy |
5,985
+307
| +5% | +$4.43K | ﹤0.01% | 2525 |
|
|
2016
Q4 | $72K | Sell |
5,678
-1,596
| -22% | -$29.7K | ﹤0.01% | 2659 |
|
|
2016
Q3 | $203K | Buy |
7,274
+350
| +5% | +$11.7K | ﹤0.01% | 2088 |
|
|
2016
Q2 | $242K | Sell |
6,924
-1,710
| -20% | -$53.8K | ﹤0.01% | 1966 |
|
|
2016
Q1 | $236K | Buy |
8,634
+1,748
| +25% | +$51.5K | ﹤0.01% | 1999 |
|
|
2015
Q4 | $235K | Buy |
6,886
+6,563
| +2,032% | +$205K | ﹤0.01% | 1980 |
|
|
2015
Q3 | $9K | Buy |
323
+107
| +50% | +$4.58K | ﹤0.01% | 3734 |
|
|
2015
Q2 | $10K | Buy |
+216
| New | +$8.13K | ﹤0.01% | 3816 |
|
Other funds holding DPLO
PNC Financial Services Group's DPLO Position: Q1 2020 in Review
PNC Financial Services Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 397 shares — an estimated $2K sold.
PNC Financial Services Group first reported a position in DPLO in Q2 2015 and held it in 19 quarters. The position peaked at $414K in Q4 2017. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- PNC Financial Services Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- PNC Financial Services Group sold 397 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $2K.
- PNC Financial Services Group first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 19 quarters.
- PNC Financial Services Group's DIPLOMAT PHARMACY, INC. position peaked at $414K in Q4 2017.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on PNC Financial Services Group's 13F filing for Q1 2020, filed 8 May 2020.